Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma

Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma

Glioblastoma (GBM), the most aggressive astrocytic glioma, remains a therapeutic challenge despite multimodal approaches. Immunotherapy holds promise, but its efficacy is hindered by the highly immunosuppressive GBM microenvironment. This review underscores the urgent need to comprehend the intricat...

Full description

Bibliographic Details
Main Authors: Somaya A. Abdel-Rahman, Moustafa Gabr
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
small molecules
immune checkpoints
glioblastoma
drug discovery
immunomodulation
immunosuppression
Online Access:https://www.mdpi.com/2072-6694/16/2/435

Internet

https://www.mdpi.com/2072-6694/16/2/435

Similar Items